Literature DB >> 28219770

Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2.

Amel Badawi1, Stephanie Hehlgans2, Josef Pfeilschifter1, Franz Rödel2, Wolfgang Eberhardt3.   

Abstract

Increased abundance of the mRNA-binding protein human antigen R (HuR) is a characteristic feature of many cancers and frequently associated with a high grade malignancy and therapy resistance. HuR elicits a broad cell survival program mainly by stabilizing or increasing the translation of mRNAs coding for anti-apoptotic effector proteins. Conversally, we previously identified the pro-apoptotic caspase-2 as a novel HuR target which is mainly regulated at the level of translation. In this study, we investigated whether siRNA-mediated HuR knockdown interferes with cell survival and radiation sensitivity by monitoring apoptosis, DNA repair and three-dimensional (3D) clonogenic survival. We observed a significant elevation in caspase-2 upon HuR depletion and in turn, a sensitization of colorectal DLD-1 and HCT-15 cells to radiation-induced apoptosis as implicated by the dose-dependent elevation of sub-G1 phase cell entry and increased caspase-2, -3 and poly ADP-ribose polymerase (PARP)-cleavage, respectively. Coincidentally, HuR deficiency significantly elevated the number of radiation-induced γH2AX/53BP1-positive foci indicating an increase in DNA damage. Accordingly, the irradiation-dependent reduction in clonogenic cell survival was further impaired after knockdown of HuR. Importantly, HuR knockdown remained ineffective to radiation-induced cell responses after additional knockdown of caspase-2. Furthermore, by using RNA-pull down assay we demonstrate that irradiation (6 Gy) robustly increased HuR binding to caspase-2 mRNA. Collectively, sensitization of colon carcinoma cells to radiation-induced cell death and DNA-damage by HuR knockdown critically depends on caspase-2 and may represent a valuable approach to intervene with therapy resistance of colorectal cancer (CRC).
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Caspase-2; Colorectal carcinoma cells; HuR; Radiotherapy resistance

Mesh:

Substances:

Year:  2017        PMID: 28219770     DOI: 10.1016/j.canlet.2017.02.010

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

Review 1.  Drug delivery approaches for HuR-targeted therapy for lung cancer.

Authors:  Rajeswari Raguraman; Santny Shanmugarama; Meghna Mehta; Jo Elle Peterson; Yan D Zhao; Anupama Munshi; Rajagopal Ramesh
Journal:  Adv Drug Deliv Rev       Date:  2021-11-22       Impact factor: 15.470

2.  Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.

Authors:  Zili Zhang; Zhen Yao; Ling Wang; Hai Ding; Jiangjuan Shao; Anping Chen; Feng Zhang; Shizhong Zheng
Journal:  Autophagy       Date:  2018-08-21       Impact factor: 16.016

Review 3.  Understanding and targeting the disease-related RNA binding protein human antigen R (HuR).

Authors:  Christopher W Schultz; Ranjan Preet; Teena Dhir; Dan A Dixon; Jonathan R Brody
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-01-23       Impact factor: 9.957

4.  Inhibition of TDP43-Mediated SNHG12-miR-195-SOX5 Feedback Loop Impeded Malignant Biological Behaviors of Glioma Cells.

Authors:  Xiaobai Liu; Jian Zheng; Yixue Xue; Chengbin Qu; Jiajia Chen; Zhenhua Wang; Zhen Li; Lei Zhang; Yunhui Liu
Journal:  Mol Ther Nucleic Acids       Date:  2017-12-08       Impact factor: 8.886

5.  HuR stabilizes TFAM mRNA in an ATM/p38-dependent manner in ionizing irradiated cancer cells.

Authors:  Rui Zhang; Jun Wang
Journal:  Cancer Sci       Date:  2018-06-28       Impact factor: 6.716

6.  The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells.

Authors:  Lorenzo Allegri; Federica Baldan; Sudeshna Roy; Jeffrey Aubé; Diego Russo; Sebastiano Filetti; Giuseppe Damante
Journal:  Sci Rep       Date:  2019-05-14       Impact factor: 4.996

7.  Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.

Authors:  Yichen Song; Lianqi Shao; Yixue Xue; Xuelei Ruan; Xiaobai Liu; Chunqing Yang; Jian Zheng; Shuyuan Shen; Jiajia Chen; Zhen Li; Yunhui Liu
Journal:  J Exp Clin Cancer Res       Date:  2019-06-11

8.  Inhibition of IRES-dependent translation of caspase-2 by HuR confers chemotherapeutic drug resistance in colon carcinoma cells.

Authors:  Amel Badawi; Abhiruchi Biyanee; Usman Nasrullah; Sofia Winslow; Tobias Schmid; Josef Pfeilschifter; Wolfgang Eberhardt
Journal:  Oncotarget       Date:  2018-04-06

Review 9.  The RNA-Binding Protein HuR in Digestive System Tumors.

Authors:  Xiaoqing Song; Xin Shi; Wenjuan Li; Fa Zhang; Zhonglin Cai
Journal:  Biomed Res Int       Date:  2020-07-24       Impact factor: 3.411

10.  Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib.

Authors:  Stephanie Hehlgans; Patrick Booms; Ömer Güllülü; Robert Sader; Claus Rödel; Panagiotis Balermpas; Franz Rödel; Shahram Ghanaati
Journal:  Int J Mol Sci       Date:  2018-08-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.